Evaluation of the Washington Intensive Supervision Program

Behavior Clinical Trial

Official title:

Evaluation of the Washington Intensive Supervision Program

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01343472
• Other study ID #: SPP0311F08
• Status: Completed
• Phase: N/A
• First received: April 26, 2011
• Last updated: April 6, 2018
• Start date: January 2011
• Est. completion date: June 2012

Study information

• Verified date: April 2018
• Source: Pepperdine University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU).

Description:

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). WISP is a program targeting high-risk parolees in Seattle, and is modeled after the HOPE program in Hawaii. The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU) on a number of outcomes, including drug use, missed appointments, recidivism, prison and jail stays, and parole revocations. WISP uses regular random drug testing and close community supervision, paired with swift and certain, but modest sanctions for every detected violation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: June 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Inmates released by DOC to community corrections supervision

• Supervised out of the Seattle CJC (Community Justice Center) to include field offices and offenders from the downtown "Metro" unit, Southeast Seattle unit, Northgate (north Seattle) and West Seattle.

• Have a parole supervision discharge date at least one year from the date of release from entry into WISP

Exclusion Criteria:

• Level III Sex Offenders

• Existing assignment to supervision that precludes WISP. These include: Drug Offender Sentencing Alternative (DOSA)and Special Sex Offender Sentencing Alternative (SSOSA).

• Dangerously Mentally Ill (DMIO)

Related Conditions & MeSH terms

• Behavior
• Drug Users

Intervention

Behavioral:
• WISP supervision
WISP entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). WISP includes regular random drug testing.
• Parole-as-usual
Parolees are supervised under standard parole supervision practice in Washington State.

Locations

Country	Name	City	State
United States	Seattle Community Justice Center	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
Pepperdine University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Revocation rate	Percentage of subjects in each condition who are revoked from parole and returned to prison	12 months
Secondary	% positive drug tests	Percentage of random and scheduled drug tests that test positive for illicit drugs	12 months
Secondary	Days incarcerated	Total number of days incarcerated in jail or prison	12 months
Secondary	% Missed appointments	Percentage of parole appointments that are missed.	12 months
Secondary	New arrests	Number of new arrests.	12 months
Secondary	Assessed risk	Parolee risk assessment (high, medium, low)	12 months